Biohit Oyj (BIOBV.HE)
EUR 2.72
(-1.2%)
EUR 2.72
(-1.2%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.12 EUR | 200.0% |
| 2022 | 0.04 EUR | 140.12% |
| 2021 | -0.10 EUR | 54.68% |
| 2020 | -0.22 EUR | -133.05% |
| 2019 | -0.09 EUR | 32.57% |
| 2018 | -0.14 EUR | -133.33% |
| 2017 | 0.42 EUR | 290.91% |
| 2016 | -0.22 EUR | -10.0% |
| 2015 | -0.20 EUR | -140.1% |
| 2014 | -0.08 EUR | 80.63% |
| 2013 | -0.43 EUR | -59.26% |
| 2012 | -0.27 EUR | -109.44% |
| 2011 | 2.86 EUR | 60751.06% |
| 2010 | 0.00 EUR | -84.33% |
| 2009 | 0.03 EUR | -57.14% |
| 2008 | 0.07 EUR | 158.33% |
| 2007 | -0.12 EUR | -85.19% |
| 2006 | -0.06 EUR | -270.29% |
| 2005 | -0.02 EUR | -33.59% |
| 2004 | -0.01 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.04 EUR | -1.0% |
| 2024 Q1 | 0.04 EUR | 20.85% |
| 2023 FY | - EUR | 200.0% |
| 2023 Q1 | 0.04 EUR | 326.13% |
| 2023 Q2 | 0.09 EUR | 106.22% |
| 2023 Q3 | 0.01 EUR | -83.94% |
| 2023 Q4 | 0.03 EUR | 122.15% |
| 2022 Q3 | -0.01 EUR | -116.56% |
| 2022 Q1 | 0.03 EUR | 212.41% |
| 2022 FY | - EUR | 140.12% |
| 2022 Q4 | -0.02 EUR | -101.01% |
| 2022 Q2 | 0.06 EUR | 100.0% |
| 2021 FY | - EUR | 54.68% |
| 2021 Q4 | -0.03 EUR | -77.33% |
| 2021 Q1 | -0.04 EUR | 44.96% |
| 2021 Q3 | -0.02 EUR | 79.48% |
| 2021 Q2 | -0.07 EUR | -99.73% |
| 2020 Q3 | -0.04 EUR | 76.67% |
| 2020 FY | - EUR | -133.05% |
| 2020 Q2 | -0.15 EUR | -96.34% |
| 2020 Q1 | -0.08 EUR | -43.61% |
| 2020 Q4 | -0.07 EUR | -90.0% |
| 2019 Q3 | -0.03 EUR | 32.42% |
| 2019 Q4 | -0.05 EUR | -96.31% |
| 2019 FY | - EUR | 32.57% |
| 2019 Q2 | -0.04 EUR | -100.5% |
| 2019 Q1 | -0.02 EUR | 47.78% |
| 2018 FY | - EUR | -133.33% |
| 2018 Q3 | -0.04 EUR | -9.43% |
| 2018 Q2 | -0.04 EUR | 0.0% |
| 2018 Q1 | -0.04 EUR | 3.05% |
| 2018 Q4 | -0.04 EUR | 0.0% |
| 2017 Q3 | -0.04 EUR | -115.04% |
| 2017 Q1 | 0.24 EUR | 692.59% |
| 2017 Q4 | -0.04 EUR | 0.0% |
| 2017 FY | - EUR | 290.91% |
| 2017 Q2 | 0.24 EUR | 0.0% |
| 2016 Q3 | -0.04 EUR | 43.59% |
| 2016 Q1 | -0.07 EUR | 24.58% |
| 2016 FY | - EUR | -10.0% |
| 2016 Q4 | -0.04 EUR | 0.0% |
| 2016 Q2 | -0.07 EUR | 0.0% |
| 2015 Q3 | -0.01 EUR | 75.0% |
| 2015 Q2 | -0.03 EUR | 56.04% |
| 2015 Q1 | -0.06 EUR | 22.69% |
| 2015 Q4 | -0.10 EUR | -1260.0% |
| 2015 FY | - EUR | -140.1% |
| 2014 Q1 | 0.17 EUR | 241.67% |
| 2014 FY | - EUR | 80.63% |
| 2014 Q4 | -0.08 EUR | -28.35% |
| 2014 Q3 | -0.06 EUR | 31.56% |
| 2014 Q2 | -0.09 EUR | -155.18% |
| 2013 Q3 | -0.07 EUR | 63.78% |
| 2013 Q4 | -0.12 EUR | -84.05% |
| 2013 Q1 | -0.07 EUR | -16.69% |
| 2013 Q2 | -0.18 EUR | -145.23% |
| 2013 FY | - EUR | -59.26% |
| 2012 FY | - EUR | -109.44% |
| 2012 Q3 | -0.06 EUR | 33.26% |
| 2012 Q2 | -0.09 EUR | -33.28% |
| 2012 Q4 | -0.06 EUR | -6.97% |
| 2012 Q1 | -0.07 EUR | -102.34% |
| 2011 Q4 | 2.83 EUR | 6975.0% |
| 2011 Q1 | - EUR | 100.0% |
| 2011 Q2 | -0.01 EUR | 0.0% |
| 2011 Q3 | 0.04 EUR | 619.48% |
| 2011 FY | - EUR | 60751.06% |
| 2010 Q2 | 0.01 EUR | 0.0% |
| 2010 Q3 | -0.02 EUR | -255.0% |
| 2010 Q1 | 0.01 EUR | -80.0% |
| 2010 Q4 | -0.00 EUR | 80.65% |
| 2010 FY | - EUR | -84.33% |
| 2009 Q1 | -0.01 EUR | 0.0% |
| 2009 FY | - EUR | -57.14% |
| 2009 Q4 | 0.05 EUR | 422.58% |
| 2009 Q3 | -0.02 EUR | 0.0% |
| 2009 Q2 | - EUR | 100.0% |
| 2008 FY | - EUR | 158.33% |
| 2007 FY | - EUR | -85.19% |
| 2006 FY | - EUR | -270.29% |
| 2005 FY | - EUR | -33.59% |
| 2004 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Herantis Pharma Oyj | 0.02 EUR | -636.196% |
| Nanoform Finland Oyj | -0.26 EUR | 146.154% |